Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus.
Increased release of renal adenosine and stimulation of renal adenosine receptors have been proposed to be major mechanisms in the development of contrast media-induced acute renal failure (CM-ARF). Patients with diabetes mellitus or preexisting renal disease who have reduced renal function have a markedly increased risk to develop CM-ARF. This increased risk to develop CM-ARF in patients with diabetes mellitus is linked to a higher sensitivity of the renal vasculature to adenosine, since experimental studies have shown increased adenosine-induced vasoconstriction in the kidneys of diabetic animals. Furthermore, recent evidence suggests that administration of adenosine receptor antagonists reduces the risk of development of CM-ARF in both diabetic and nondiabetic patients. The purpose of this review is to discuss the role of adenosine in the development of CM-ARF, particularly in the kidneys of diabetic patients, and to evaluate the therapeutic potential of adenosine receptor antagonists in the prevention of CM-ARF. Selective adenosine A1 receptor antagonists may provide a therapeutic tool to prevent CM-ARF in patients with diabetes mellitus and reduced renal function.
Pflueger
A
A
Department of Physiology and Biophysics, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Larson
T S
TS
Nath
K A
KA
King
B F
BF
Gross
J M
JM
Knox
F G
FG
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control; D000241:Adenosine / Q000378:metabolism*; D003287:Contrast Media / Q000009:adverse effects*; D048909:Diabetes Complications; D006801:Humans; D009994:Osmolar Concentration; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1 / Q000378:metabolism; D012307:Risk Factors
D003287:Contrast Media; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1; D000241:Adenosine